Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jsap.13780 | DOI Listing |
J Neurosurg Case Lessons
December 2024
Department of Neurological Surgery, University of California, San Francisco, San Francisco, California.
Background: Metastatic follicular thyroid carcinoma to the central nervous system (CNS), including the skull and dura, is exceedingly rare.
Observations: The authors present the case of a gigantic, intraosseous, dural-based follicular thyroid carcinoma, highlighting the operative strategy for this mass. They also provide a literature review of CNS metastases of differentiated thyroid carcinoma.
J Small Anim Pract
December 2024
Laboratory of Veterinary Neurology, Nihon University, Kanagawa, Japan.
J Stroke Cerebrovasc Dis
July 2021
Department of Neurology, Medical College of Georgia, Augusta University, Augusta, 1120 15th Street BI3076, GA, United States.
Objective: Decompressive craniectomy (DC) improves functional outcomes in selected patients with malignant hemispheric infarction (MHI), but variability in the surgical technique and occasional complications may be limiting the effectiveness of this procedure. Our aim was to evaluate predefined perioperative CT measurements for association with post-DC midline brain shift in patients with MHI.
Methods: At two medical centers we identified 87 consecutive patients with MHI and DC between January 2007 and December 2019.
Interv Neuroradiol
April 2018
2 12275 Department of Neurological Surgery, Washington University, St. Louis, MO, USA.
We report a case of renal cell carcinoma (RCC) metastasis to the calvarium and describe a strategy for percutaneous embolization of hypervascular calvarial tumors with intracranial extension. An elderly patient with history of RCC presented with left-sided weakness. Imaging studies showed a large right frontoparietal calvarial mass with intra- and extracranial extension.
View Article and Find Full Text PDFJ Pediatr Hematol Oncol
March 2014
Fox Chase Cancer Center, Temple University, Philadelphia, PA.
Nearly 75% of childhood cancer survivors will experience an adverse late effect from previous therapy. In patients previously treated with cranial irradiation, the late effect can manifest as secondary central nervous system tumors. Presented is a case of a 20 year man with a history of T-cell lymphoblastic leukemia diagnosed at age 22 months, treated with chemotherapy and cranial irradiation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!